Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2015.
|
| Edición: | 1st ed. 2015. |
| Colección: | Methods in Pharmacology and Toxicology,
|
| Materias: |
Tabla de Contenidos:
- Histopathology: A Canvas and Landscape of Disease in Drug and Diagnostic Development
- A Field Guide to Homo morphologicus for Biomedical Scientists, Or How to Convey an Understanding of Pathology to Scientists in a Biopharma Enterprise
- Outsourcing Tissue Histopathology Investigations in Support of Clinical Trials for Novel Therapeutics: Considerations and Perspectives
- Histopathology in Mouse Models of Rheumatoid Arthritis
- Markers Used for Visualization and Quantification of Blood Vessels and Lymphatic Vessels
- Practical Approaches to Microvessel Analysis: Hotspots, Microvessel Density, and Vessel Proximity
- Quantitative Histopathology and Alternative Approaches to Assessment of Fibrosis for Drug Development in Hepatitis C and Nonalcoholic Steatohepatitis
- Stereology and Computer-Based Image Analysis Quantifies Heterogeneity and Improves Reproducibility for Grading Reticulin in Myeloproliferative Neoplasms
- Image Analysis Tools for Quantification of Spinal Motor Neuron Subtype Identities
- Development of a Tissue Image Analysis Algorithm for Celiac Drug Development
- Quantitative Histopathology for Evaluation of In Vivo Biocompatibility Associated with Biomedical Implants
- Quantitative Histomorphometry and Quantitative Polymerase Chain Reaction (PCR) as Assessment Tools for Product Development
- Measuring the Messenger: RNA Histology in Formalin Fixed Tissues
- Algorithm-Driven Image Analysis Solutions for RNA ISH Quantification in Human Clinical Tissues
- Solid Tissue-Based DNA Analysis by FISH in Research and Molecular Diagnostics
- Preanalytic Considerations for Molecular Genomic Analyses of Tissue
- Next Generation Sequencing (NGS) in Anatomic Pathology Discovery and Practice
- The Impact of Pre-Analytic Variables on Tissue Quality from Clinical Samples Collected in a Routine Clinical Setting: Implications for Diagnostic Evaluation, Drug Discovery, and Translational Research
- Adapting HER2 Testing for a Different Organ: New Wine in Old Wineskins
- Tissue-Based Companion Diagnostics: Development of IHC Assays from an Industry Perspective
- Development of Tissue-Based Companion Diagnostics: The Relationship Between the Pharmaceutical Company, Diagnostic Partner, and the Biomarker Laboratory
- Navigating Regulatory Approval for Tissue-Based Companion Diagnostics
- Implementing a Multi-Analyte Immunohistochemistry Panel into a Drug Development Program
- Cutpoint Analysis and Related Statistical Methods in Digital Pathology and Companion Diagnostics.